To put it another way, are industry funded trials more or less likely to find positive results for the funding body?
The two systematic reviews I referred to in the thread did both find this but it's true that they were not very recent (2004 and 2013). Would be interesting to see an updated piece of research
-
-
Found what exactly? That negative trials less likely to be published, or that there was a difference between industry and others in the extent of publication bias?
-
That industry trials were significantly more likely to be positive (in one case by a wide margin) than non-industry
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.